Clinical Trial Update: HyBryte (Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCL [Phase 2]

View source ↗

Summary

Phase 2 trial comparing HyBryte (synthetic hypericin) to Valchlor (mechlorethamine gel) for Cutaneous T-Cell Lymphoma/Mycosis Fungoides has completed and result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous T-cell Lymphoma
• Mycosis Fungoides

Drugs mentioned

• HyBryte (synthetic hypericin)
• Valchlor (mechlorethamine)

Snippet

Sponsor: Soligenix | Conditions: Cutaneous T-Cell Lymphoma/Mycosis Fungoides | Phase 2 | Status: COMPLETED | Results posted: 2025-08-20